AstraZeneca and Oxford University aim to produce the next generation of Covid-19 vaccines that will protect against variants as soon as the autumn, a senior executive at the British drugmaker said on Wednesday.Asked when AstraZeneca could produce a next-generation vaccine to tackle new variants, AstraZeneca research chief Mene Pangalos said “as rapidly as possible”.”We’re working very hard and we’re already talking about not just the variants that we have to make in laboratories, but also the clinical studies that we need to run,” he said in a briefing with media.”We’re very much aiming to try and have something ready by the autumn, so this year.”The partners are getting close to having data on the efficacy of their Covid-19 vaccine on older adults, Professor Andrew Pollard, director of the Oxford Vaccine Group, said.
- Oxford University to recruit 500 volunteers for COVID-19 vaccine trial
- Covid-19 vaccine: Research on at Oxford lab, clinical trial on humans soon
- COVID-19 vaccine trial: Oxford University to recruit 500 volunteers
- Oxford recruiting volunteers for speedy Covid-19 vaccine trial
- Genetic sequencing takes lead in Covid-19 vaccine development
- Israeli Scientists: Human Trials for COVID-19 Vaccine Prototype to Start in June
- Bill Gates Simultaneously Backs Seven COVID-19 Vaccine Trials to Accelerate Research
- Australian researchers begin testing COVID-19 vaccines
- Why the World Health Organization’s Response to COVID-19 Is Crucial to the Future of Public Health
- Covid-19 update: Scope of antibody tests rigid despite panel push
AstraZeneca, Oxford expects 'next generation' Covid-19 vaccine to tackle variants by autumn - executive have 231 words, post on health.economictimes.indiatimes.com at February 3, 2021. This is cached page on Vietnam Art News. If you want remove this page, please contact us.